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A B S T R A C T
We report a case of immeasurable levels of serum phosphate in a patient with juvenile type Diabetes mellitus and dia-
betic ketoacidosis who developed respiratory failure. A 27-year-old female with juvenile type insulin-dependent Diabetes
mellitus was admitted because of suspected acute mediastinitis and respiratory failure, probably, among other responsi-
ble factors, caused and complicated by undetectable levels of serum phosphate. The serum phosphate concentration three
days after aggressive treatment was only 0.2 mmol/L. Furthermore, a significant improvement in weakness and lethargy
was observed. To the best of our knowledge, this is the first described case of immeasurable levels of serum phosphate. In
patients with Diabetes mellitus, serum phosphate concentrations should be routinely checked in order to avoid addi-
tional complications.
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Introduction
Phosphorus is the sixth most common element in the
body after oxygen, hydrogen, carbon, nitrogen, and cal-
cium and is the most abundant intracellular anion1. Se-
vere hypophosphatemia (<1.0 mg/dL or 0.3 mmol/L) has
significant morbidity and is associated with a very high
mortality (30%)2,3. It can be the result of a decrease in
phosphorus absorption from the gastrointestinal tract,
an intracellular shift of phosphorus, or an increase in the
renal excretion of phosphorus4,5. Hypophosphatemia is
observed in approximately 28% of critically ill and 3% of
hospitalized patients. The causes of hypophosphatemia
in intensive care unit (ICU) can be subdivided into three
categories: inadequate intake; redistribution of phos-
phate into cells; and loss of phosphate from the body6.
Clinical consequences of hypophosphatemia are rhab-
domyolysis; hypophosphatemic osteomalacia; hemolysis;
leukocyte dysfunction; respiratory failure including im-
paired contractile properties of the diaphragm and re-
fractory weaning from the ventilator; impaired myocar-
dial performance; diabetic ketoacidosis and perturbed
central nervous system7,8.
Hypophosphatemia has been well documented in pa-
tients with severe trauma, induced hypothermia for brain-
-injured patients and head injury, drug- and nutrition-in-
duced, in bulimic patient, in patients receiving special-
ized nutrition support, and in patients after major sur-
gery and in particular after cardiac surgery8–14. Inorganic
phosphate and serum albumin are two substances that
act as non-volatile weak acids and have concentrations in
plasma great enough so that changes in them can pro-
duce significant acid-base disturbances15.
Hypophosphatemia has long been reported to be asso-
ciated with sepsis and gram-negative infections and has
been correlated with sepsis severity16. Shor et al.16 found
that 80.8% of the patients with sepsis with severe hypo-
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phosphatemia died, vs. 34.5% of the patients without se-
vere hypophosphatemia. They also found that being in
the severe hypophosphatemic group increased the risk of
death by nearly 8-fold and their findings indicated that
severe hypophosphatemia can serve as an independent
mortality predictor in sepsis. Hoffman et al. found that
sepsis was implicated as a contributing factor in 26% of
patients with severe hypophosphatemia. They concluded
that regular phosphate determination is recommended
in ICU patients to facilitate early diagnosis of hypopho-
sphatemia3.
Hypophosphatemia and acute respiratory failure in a
diabetic patient17–19, as a cause of failed weaning20, and
as a reversible cause of refractory ventilatory failure21
have been previously well documented. Several studies
have suggested that diabetes is associated with impaired
pulmonary function; however, previous studies have pre-
sented this relationship to be inconsistent22.
Herein we present case of respiratory insufficiency as-
sociated with hypophosphatemia in a juvenile type Dia-
betes mellitus.
Case Report
A 27-year old female patient was transferred to our
ICU because of respiratory insufficiency caused by sus-
pected acute mediastinitis. The patient had a history of
juvenile type Diabetes mellitus, and had been hospital-
ized in another hospital for 3 months previous because of
sepsis caused by Escherichia coli in her urinary tract,
poor nutritional status, diabetic gastroenteropathy, fre-
quent vomiting and diarrhea. During cannulation of the
right subclavian vein, an iatrogenic catheter-induced pne-
umothorax developed and chest drainage was performed.
Three days later, CT findings revealed unilateral right-
-sided pleural effusion and anterior pneumomediasti-
num. Lung infiltration occurred and a diagnostic fiberop-
tic bronchoscopy and microbiologic analysis of endotra-
cheal aspirates was performed. A bronchoalveolar lavage
was also performed. Empirical antibiotic therapy was im-
mediately administered with amoxicillin plus clavulanic
acid and metronidazol and netromycin and the patient
was transferred to our thoracic surgery ICU. On admis-
sion, the patient was confused, disorientated, barely mo-
bile, edematous, pale, lethargic, and afebrile, with hypo-
reflexia and weakness of the skeletal muscle observed.
Invasive measured blood pressure was 127/76 mm Hg.
An electrocardiogram revealed tachycardia (126 beats/
min). Arterial oxygen saturation measured by pulse oxi-
metry was approximately 87–89%. Arterial blood gas re-
sults were pH 7.389; pCO2 3.24 kPa; pO2 7.23 kPa; SaO2
89.1% and breath rate 30 breaths/min. Because of hypo-
xia caused by respiratory insufficiency, we applied oxy-
gen therapy via face mask at 5 l/min, and SaO2 was ap-
proximately 92%. Laboratory findings presented anaemia
(RBC 2.72´1012/L, haemoglobin concentration 8.1 g/dL,
haematocrit 0.247 l/L); WBC 10.2´109/L; total serum
protein content 47 g/L; blood glucose values up to 24
mmol/L refractory to insulin; and potassium 5.3 mmol/L.
The central vein catheter, which had been placed in an-
other hospital, was located beneath the skin. On admis-
sion, we have inserted a catheter into the internal jugu-
lar vein for measurement of central venous pressure (1
cm H2O on admission) and infusions. A fiberoptic bron-
choscopy and esophagoscopy with contrast were per-
formed and spontaneous perforation of the oesophagus,
as a possible cause of suspected mediastinitis was ex-
cluded. Although we have not proven respiratory infec-
tion, we continued prophylactic antibiotic therapy, which
was already started in another hospital.
Initial laboratory values included a serum inorganic
phosphate of 0.00 mmol/L (normal range 0.79–1.42 mmol/
L). A repeat test (photometry with ammonium molyb-
date, Hitachi 912, Boehringer/Mannheim) revealed the
same result. Serum sodium, urea, nitrogen, bilirubin and
creatinine values were within a normal range. Volume
resuscitation (3000 mL of saline) was initiated and four
doses of packed red cell transfusion and analgesic ther-
apy were administered. In addition, continuous IV infu-
sion of insulin (8 i.u/h) and 0.06 mg (0.02 mmol/kg/h) of
potassium phosphate salts (K2PO4, diluted in 250 mL of
saline 0.9%) was administered. Neurologist was con-
sulted and he found general muscle weakness caused by
diabetic polineuropathy. However, on the third day after
treatment was initiated, the serum inorganic phosphate
concentration was only 0.2 mmol/L. At the same time,
hyperglycemia and acidosis were normalized and respira-
tory distress and weakness were significantly improved.
A control chest radiograph revealed complete re-expan-
sion of lung parenchyma and lack of effusion. Arterial ox-
ygen saturation was >94% without oxygen therapy. The
patient’s recovery was uneventful; although twelve days
after phosphate replacement commenced the serum phos-
phate concentration was only 0.3 mmol/L.
Discussion
During a computerized search of the literature, no re-
ports regarding serum »aphosphatemia« were found. Hy-
pophosphatemia is observed in approximately 2–3% of
hospitalized patients, but is reported to be as high as 30%
in the critically ill1. Severe hypophosphatemia occurs in
no more than 0.5% of hospitalized patients. Neverthe-
less, it is difficult to provide precise estimates of how
many patients are seen with hypophosphatemia per an-
num. This is further complicated by the use of chemistry
panels that do not measure inorganic phosphate unless
specifically ordered. As it was in our case, this often leads
to a delay in correct diagnosis, and, therefore, additional
delay in management. Severe hypophosphatemia beco-
mes clinically significant when there is underlying phos-
phate depletion. A high index of suspicion alone avoids
the unnecessary withholding of treatment that can be
life saving2.
Hypophosphatemia is a common complication during
diabetic ketoacidosis therapy where it is seldom severe
and rarely causes clinical manifestations. The clinical
manifestations of mild hypophosphatemia are typically
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minor and nonspecific: myalgia; weakness; and anorexia.
However, when the imbalance is severe, critical compli-
cations including tetany, coma, rhambdomyolysis, sei-
zures, skeletal muscle weakness, respiratory muscles fa-
tigue, respiratory failure and ventricular tachycardia
may occur7,10,23,24.
Phosphate is a necessary product, which provides en-
ergy for almost all cell functions. Herein, insulin-depend-
ent Diabetes mellitus was further complicated as a result
of long duration nutritional disorders, vomiting, diar-
rhea and infection. The use of additional insulin enables
phosphate to re-enter the cell, thus lowering serum phos-
phate concentration. Hematologic abnormalities corre-
late with reductions in intracellular ATP and 2,3-diphos-
phoglycerate and may include erythrocyte microspherocy-
tosis and hemolysis, which might explain the hemolytic
anemia observed in our patient.
Hypophosphatemia is the most well known, and per-
haps most significant element of the refeeding syndrome
(RFS). Although nausea, vomiting, and diarrhea often
predispose to RFS25,26, we believe that RFS was not a
likely cause of hypophosphatemia in our patient.
Our patient’s clinical condition was seriously wors-
ened in another hospital as a result of effusion and iatro-
genic pneumothorax following cannulation of the right
subclavian vein, which further contributed to the devel-
opment of respiratory insufficiency and suspected media-
stinitis. During the stay in our Department, we didn’t
confirm either respiratory infection or consequential ef-
fusion of infectious aetiology and mediastinitis. A large
part of the clinical condition of our patient was caused
iatrogenic. Suspicion of mediastinitis was further em-
phasized by history of severe vomiting that is often de-
scribed as a cause of rupture of the oesophagus and the
resulting mediastinitis. Sepsis caused by urinary tract
infection is well known in diabetic patients, and it was
certainly one of the major causes of reducing the concen-
tration of serum phosphate in our patient, but not the
only reason. Urinary tract infection was cured in another
hospital, but the patient’s clinical condition further dete-
riorated in another hospital due to vomiting, diarrhea,
dehydration, and insulin refractory hyperglycaemia. All
this has led to severe metabolic disorders. Consultative
psychiatrist in another hospital found in our patient per-
sonality disorder from the sphere of feeding. It is well
known that the juvenile type Diabetes mellitus causes
many metabolic disorders and we reasonably suspected
that the gradual loss of phosphate occurred over the
years. Most likely, patient’s organism was adapted to
gradual fluctuations in the concentration of serum phos-
phate. However, a number of circumstances during the
few months prior to admission to our ICU, led to immea-
surable levels of serum phosphate. We assume that in
this way we could explain the severe muscle weakness,
which led to respiratory muscle fatigue and somnolence,
and not to »tetanus cramps« and coma. Unfortunately,
we didn’t detect the level of parathyroid hormone, al-
though it influences the level of phosphate.
We believe that due to severe chronic deficit of serum
phosphate, a relatively aggressive substitution of the
phosphate could not achieve rapid laboratory changes.
However, the fact is that the recovery of our patient be-
gan following phosphate substitution. Unfortunately, low
phosphorus was not identified and treated at the previ-
ous hospitals attended. Although some authors recom-
mend the substitution of phosphate in a short time-
-period7,27, we could not risk additional complications
and gradually substituted phosphate by continuous IV
infusion of potassium phosphate salts. Bugg and Jones
concluded that further, appropriately designed trials are
essential before routine correction of plasma phosphate
concentrations can be recommended in ICU6.
It is generally recommended that patients with severe
hypophosphatemia (<1.0 mg/dL [0.3 mmol/L]) are trea-
ted to avoid potential detrimental consequences. Severe
hypophosphatemia in critically ill, intubated patients or
those with clinical sequelae should be managed with in-
travenous replacement therapy (0.08–0.16 mmol/kg) over
2–6 h7.
Although the undetectable serum concentration of in-
organic phosphorus seems unlikely it was confirmed on
repeat testing, this may have been because of laboratory
error. Depending on the assay used, it is possible that the
concentration of phosphate was too low to detect using
that method. Might the value have been >0.00 if per-
formed in a different laboratory? If the measurement
system could be changed to a more accurate one, a sys-
tem capable of measuring concentrations from mmol/L
to mmol/L, certain concentrations of serum phosphate
might be present in the samples. As far as we could, we
excluded laboratory error. Unfortunately, we were not
able to verify the values of serum phosphate on another
appliance in another laboratory.
In summary, this report describes a patient with juve-
nile type Diabetes mellitus and diabetic ketoacidosis who
developed respiratory failure probably, among other re-
sponsible factors, caused and complicated by undetect-
able levels of serum phosphate. Continuous infusion of
insulin and potassium phosphate was administered. The
serum phosphate was uncorrectable despite treatment
with continuous infusion of insulin and potassium phos-
phate and three days later, the serum phosphate concen-
tration was only 0.2 mmol/L. Furthermore, a significant
improvement in weakness and lethargy was observed. To
the best of our knowledge, this is the first described case
of immeasurable levels of serum phosphate. Hypophos-
phatemia is an underdiagnosed problem in critically ill
patients, and in patients with Diabetes mellitus, serum
phosphate concentrations should be routinely checked in
order to avoid additional complications.
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NEMJERLJIVE VRIJEDNOSTI FOSFATA U SERUMU – NE PREPOZNATI UZROK RESPIRATORNE
SLABOSTI U BOLESNIKA S DIJABETESOM
S A @ E T A K
Prikazujemo bolesnicu s juvenilnim tipom insulin – ovisnoga dijabetes mellitusa i dijabeti~kom ketoacidozom u koje
se razvila respiratorna slabost uz nemjerljive vrijednosti fosfata u serumu. Bolesnicu smo hospitalizirali zbog sumnje
na akutni medijastinitis i respiratorne slabosti {to je vjerojatno uzrokovala i dodatno komplicirala »afosfatemija«, tj.
nemjerljiva vrijednost fosfata u serumu. Ordinirali smo kontinuiranu infuziju inzulina i kalij fosfata. Unato~ inten-
zivnome lije~enju, vrijednost fosfata u serumu nismo mogli brzo korigirati i tri dana kasnije, koncentracija fosfata u
serumu bila je samo 0,2 mmol/L. Ipak, nastupilo ne zna~ajno pobolj{anje respiratorne slabosti i letargije. Koliko je auto-
rima poznato, ovo je prvi prikaz nemjerljivih vrijednosti fosfata u serumu, uz kriti~ki pregled literature. Koncentraciju
fosfata u serumu treba rutinski kontrolirati u bolesnika s dijabetesom da bismo izbjegli dodatne komplikacije.
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